{ }
001122334455554433221100
001122334455554433221100

market volatility presents both challenges and opportunities for investors today

On December 17, 2024, market volatility is viewed as both a threat and an opportunity for investors, with strategies like asset allocation recommended for effective navigation. Notably, Trent's shares surged 126% year-to-date, while NMDC announced a record date for 2:1 bonus shares. Direct retail inflows reached nearly ₹1 trillion, indicating growing investor confidence amid market fluctuations.

uncertainty over us biosecure act impacts shares of indian cdmo firms

Shares of contract drug manufacturing organizations, including Divi's Labs, Neuland Labs, and Piramal Pharma, faced significant declines as uncertainty surrounding the US Biosecure Act intensified. The act's exclusion from a key defense bill suggests a softening US stance on Chinese biotech, negatively impacting sentiment towards Indian CDMO players. Neuland Laboratories experienced a 9% drop, marking its largest single-day decline in over seven months, while other companies saw declines of up to 5%.

quarterly earnings reports reveal mixed results across various sectors

The Q2 earnings season for FY25 is underway, with major companies like Apollo Hospitals, Kansai Nerolac Paints, and Trident set to release their results. While many firms have reported, the overall corporate earnings scorecard has been weak, with only 62% meeting or exceeding profit expectations, particularly in the consumption sector. Notably, GAIL's earnings missed expectations due to lower gas trading margins, while Power Grid's profit remained flat year-on-year.

Piramal Pharma shows strong recovery with target price set at 310 rupees

Piramal Pharma is showing a strong recovery in 1HFY25, driven by growth in the CDMO segment, which constitutes 59% of sales. Despite trimming FY25-FY27 estimates due to higher financial leverage and supply-chain issues, the company is expected to achieve significant revenue and EBITDA growth, with a target price of INR 310. The firm is investing USD 80 million to enhance its sterile fill-finish capacities, positioning itself well for future opportunities in the market.

Q2 2024 earnings season gains momentum with major companies reporting results

Major companies including Coal India, JSW Steel, DLF, and Interglobe Aviation are set to release their Q2 earnings reports today, joining a wave of firms that have already reported results. Notable performances include Reliance Industries with a profit decline of 4.8%, while HCL Technologies and TCS reported profit increases of 10.5% and 5.0%, respectively. ICRA's profit rose by 15.6% to Rs 36.72 crore, and Oracle Financial Services Software saw a significant profit increase of 38.4% to Rs 577.70 crore.

piramal pharma reports significant profit growth in second quarter results

Piramal Pharma reported a significant increase in consolidated net profit, rising over four-fold to Rs 23 crore for Q2 FY25, compared to Rs 5 crore in the same quarter last year. Revenue from operations also saw growth, reaching Rs 2,242 crore, up from Rs 1,911 crore year-on-year.

Piramal Pharma shares rise after strong Q2 earnings and expansion plans

Piramal Pharma's stock surged 5.5% following a strong Q2 earnings report, with net profit increasing 3.5 times year-on-year to Rs 22.59 crore. The company's CDMO business, which constitutes 59% of total revenue, saw a 24% sales growth to Rs 1,320 crore, driven by rising demand for innovation-driven projects. Additionally, Piramal announced an $80 million expansion plan for its Lexington facility, aimed at enhancing sterile fill-finish capabilities by FY27.

niit and godrej properties report strong q2 earnings and industry growth

The Q2 earnings season is in full swing, with major companies like HUL, Bajaj Finserv, and TVS Motor set to release their results today. Earlier reports showed Reliance Industries' profit declined by 4.8%, while HCL Tech and TCS posted profit increases of 10.5% and 5.0%, respectively. Bajaj Finserv reported an 8.2% profit growth, reaching Rs 2,086.97 crore, alongside a 29.5% rise in total income.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.